ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
Serum 25-Hydroxyvitamin D and Health-Related Quality of Life in Patients with Papillary Thyroid Carcinoma: A Prospective Cohort Study
Yan Li
Ying Wei
Zhenlong Zhao
Lili Peng
Shuqi Li
Jie Wu
Shiliang Cao
Na Yu
Wenjia Cai
Qian Wu
Song Li
Ming-an Yu
China-Japan Friendship Hospital, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Background: The incidence of Papillary thyroid carcinoma (PTC) is rising worldwide. Despite its excellent prognosis, many PTC patients experience impaired Health-Related quality of life (HRQoL). Vitamin D exerts pleiotropic effects on musculoskeletal, immune, and psychological health, but its impact on HRQoL in PTC patients remains unclear. Methods: This prospective cohort study consecutively recruited patients with PTC from January 2024 to August 2025. Baseline serum 25-hydroxyvitamin D concentrations were measured before treatment. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) and The Thyroid Cancer-Specific Quality of Life Questionnaire (THYCA-QoL) were applied to assess HRQoL. Associations between serum 25-hydroxyvitamin D and HRQoL domains were examined using rank-transformed general linear models, spearman correlation, multivariable linear regression and binary logistic regression. A nomogram was developed to predict the probability of weight gain in HRQoL domains and evaluated using Harrell’s C-index and bootstrap calibration. Results: Among 600 patients, 27.8% had vitamin D deficiency, 69.5% had insufficiency, and 2.7% had sufficiency. Patients with sufficient vitamin D had better physical functioning and lower social functioning scores than those with deficiency or insufficiency (P = 0.002). Vitamin D was positively correlated with multiple functioning domains and negatively correlated with specific symptoms (all P < 0.05). In linear and logistic regression, higher vitamin D levels were independently associated with better physical and role functioning and fewer symptom burdens, and reduced the odds of impaired physical functioning (OR = 0.986, P = 0.016) and neuromuscular and weight gain symptoms (all P < 0.05). The nomogram showed fair discrimination (C-index 0.628) and good calibration. Conclusion: Suboptimal vitamin D status was common among patients with PTC. Higher vitamin D levels were associated with better physical and role functioning and fewer neuromuscular, psychological, and weight gain symptoms. Assessment of vitamin D status may be considered as part of supportive care when clinically indicated.
Summary
Keywords
25-hydroxyvitamin D, health-related quality of life, Papillary thyroid carcinoma, Vitamin D, Weight Gain
Received
07 January 2026
Accepted
18 February 2026
Copyright
© 2026 Li, Wei, Zhao, Peng, Li, Wu, Cao, Yu, Cai, Wu, Li and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ming-an Yu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.